Both medications suppress appetite and can affect heart rate and blood pressure, requiring close monitoring
Severe caloric restriction without adequate protein accelerates muscle loss, a problem that affects 26 to 40 percent of total weight lost in GLP-1 trials even without fasting added on top
JMP is supported by a National Institute of Health grant AR 075117
doi: 10.1038/s41591-022-02026-4 Jastreboff AM, Aronne LJ, Ahmad NN, et al
Which forms of carnosine and carnitine are best to take
Mounjaro, on the other hand, is the brand name for Tirzepatide, a somewhat newer medication that not only agonizes the GLP-1 receptor but also targets GIP (Glucose-dependent Insulinotropic Polypeptide) receptors, offering a dual mechanism of action